In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $3.90, marking a -4.88% move from the previous day.

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $4.32, marking a -3.36% move from the previous day.

We asked certified financial planners, investment advisers and other money experts their thoughts on stock choices this year ...

AI models that can learn as they go are one of the hot new areas drawing interest from both startups and the leading labs, ...

All These Sleepless Nights" director Michał Marczak finally returns with a visceral film that defies the true-crime genre.

Following a tough foray into studio filmmaking, the "Columbus" director rebounds with a DIY curio about a wayward artist's journey back to herself.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the overlooked penny stocks to invest in. On January 12, Alec ...

Abstract: In this article, the recursive filtering problem is investigated for a class of complex networks (CNs) incorporating amplify-and-forward (AF) relays and subject to double time-correlated ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...